Search clinical trials for: CJ-12420 formulation 2
Total 192 results
-
HK inno.N CorporationCompletedErosive EsophagitisKorea, Republic of
-
HK inno.N CorporationCompletedHealthyKorea, Republic of
-
HK inno.N CorporationAsan Medical CenterCompleted
-
HK inno.N CorporationCompletedNon-erosive Reflux DiseaseKorea, Republic of
-
HK inno.N CorporationCompletedHealthyKorea, Republic of
-
HK inno.N CorporationCompleted
-
HK inno.N CorporationCompletedErosive EsophagitisKorea, Republic of
-
HK inno.N CorporationCompletedGastric UlcerKorea, Republic of
-
HK inno.N CorporationCompletedGERD | Erosive EsophagitisKorea, Republic of
-
HK inno.N CorporationCompletedTo Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose AdministrationDrug Interaction | Pharmacokinetic | PharmacodynamicKorea, Republic of
-
HK inno.N CorporationCompleted
-
Sanofi Pasteur, a Sanofi CompanyImmune DesignTerminated
-
PfizerCompleted
-
Midwest Center for Metabolic and Cardiovascular...Pharmavite LLCCompletedBioavailabilityUnited States
-
AstraZenecaCompletedParkinson's DiseaseUnited Kingdom
-
HK inno.N CorporationCompletedErosive EsophagitisKorea, Republic of
-
LEO PharmaCompletedActinic KeratosisCanada, United States
-
GlaxoSmithKlineActive, not recruitingHerpes SimplexGermany, United States, Belgium, Canada, Spain, United Kingdom, Estonia, Australia
-
Boehringer IngelheimRecruitingHidradenitis SuppurativaUnited States, Korea, Republic of, Israel, Spain, Australia, Japan, Italy, Germany, Denmark, Belgium, Lithuania, China, Canada, Malaysia, Singapore, New Zealand, France, Mexico, Netherlands, Greece, United Kingdom, Bulgaria, Philipp... and more
-
Eli Lilly and CompanyCompleted
-
Vifor (International) Inc.Completed
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV Infections | Infection, Human Immunodeficiency VirusUnited States
-
Boehringer IngelheimRecruitingSmall Cell Lung Carcinoma | Neuroendocrine NeoplasmsUnited States, Belgium, Spain, Korea, Republic of, United Kingdom, Germany, Japan, China, Taiwan, France, Portugal, Bulgaria
-
Boehringer IngelheimCompleted
-
Imperial Brands PLCNerudia LtdCompleted
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Atea Pharmaceuticals, Inc.Hoffmann-La RocheCompleted
-
MedImmune LLCCompletedType 2 Diabetes MellitusUnited States
-
Janssen Research & Development, LLCCompleted
-
PfizerActive, not recruitingHealthy ParticipantsUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineRecruiting
-
Sanofi Pasteur, a Sanofi CompanyTerminatedCOVID-19United States, Australia, Brazil, Honduras
-
Boehringer IngelheimCompleted
-
National Research Council, SpainHospital Universitario Reina Sofia de CordobaCompletedColorectal CancerSpain
-
Aragon Pharmaceuticals, Inc.Completed
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency Virus | Infections, Human Immunodeficiency Virus and HerpesviridaeUnited States
-
Pendulum TherapeuticsTerminatedType 2 Diabetes MellitusIreland
-
Boehringer IngelheimCompleted
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Emory UniversityMicron Biomedical, IncCompletedVaccination | Skin AbsorptionUnited States
-
Emergent BioSolutionsNational Institute of Allergy and Infectious Diseases (NIAID); Department of...CompletedBacillus Anthracis (Anthrax) InfectionUnited States
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsGermany, Estonia, Belgium, France
-
AllerganCompletedOcular Hypertension | Primary Open-Angle GlaucomaUnited States
-
GlaxoSmithKlineCompleted
-
Chong Kun Dang PharmaceuticalUnknown
-
GlaxoSmithKlineActive, not recruiting
-
GlaxoSmithKlineCompletedRespiratory Syncytial Virus InfectionsUnited States, Belgium, Canada
-
GlaxoSmithKlineWithdrawnRespiratory Syncytial Virus InfectionsFinland, United States, Spain
-
Sanofi Pasteur, a Sanofi CompanyGlaxoSmithKlineCompletedCOVID-19Honduras, United States, Australia, France, New Zealand, Spain, United Kingdom